DISEASES AND DRUGS BUT NOT FOOD DECREASE KETOCONAZOLE BIOAVAILABILITY

被引：7

作者：

DANESHMEND, TK

机构：

[1] Department of Gastroenterology and Hepatology, University Hospital, Leiden

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1990年 / 29卷 / 06期

关键词：

D O I：

10.1111/j.1365-2125.1990.tb03705.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：783 / 784

页数：2

共 16 条

[1] DISPOSITION OF KETOCONAZOLE, AN ORAL ANTIFUNGAL, IN HUMANS [J].

BRASS, C ;

GALGIANI, JN ;

BLASCHKE, TF ;

DEFELICE, R ;

OREILLY, RA ;

STEVENS, DA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (01) :151-158

[2] EFFECT OF PH ON DISINTEGRATION AND DISSOLUTION OF KETOCONAZOLE TABLETS [J].

CARLSON, JA ;

MANN, HJ ;

CANAFAX, DM .

AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1983, 40 (08) :1334-1336

[3]

CHAPMAN JR, 1983, LANCET, V2, P510

[4] INFLUENCE OF FORMULATION ON KETOCONAZOLE PHARMACOKINETICS IN MAN - COMPARISON OF STANDARD TABLET VERSUS CAPSULE CONTAINING CITRIC-ACID [J].

DANESHMEND, TK ;

MASON, AR ;

LOWE, CH ;

WARNOCK, DW ;

JOHNSON, EM .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 (02) :289-291

[5]

DANESHMEND TK, 1984, BRIT J CLIN PHARMACO, V17, pP197

[6]

DANESHMEND TK, 1984, ANTIMICROB AGENTS CH, V25, P1, DOI 10.1128/AAC.25.1.1

[7] ORAL KETOCONAZOLE AND AMPHOTERICIN-B FOR THE PREVENTION OF YEAST COLONIZATION IN PATIENTS WITH ACUTE-LEUKEMIA [J].

DONNELLY, JP ;

STARKE, ID ;

GALTON, DAG ;

CATOVSKY, D ;

GOLDMAN, JM ;

DARRELL, JH .

JOURNAL OF HOSPITAL INFECTION, 1984, 5 (01) :83-91

[8]

Gascoigne E.R., 1981, CLIN RES REV, V1, P177

[9] THE PHARMACOKINETICS OF KETOCONAZOLE IN SEVERELY IMMUNOCOMPROMISED PATIENTS [J].

HANN, IM ;

PRENTICE, HG ;

KEANEY, M ;

CORRINGHAM, R ;

BLACKLOCK, HA ;

FOX, J ;

GASCOIGNE, E ;

VANCUTSEM, J .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1982, 10 (06) :489-496

[10]

LAKEBAKAAR G, 1988, GASTROENTEROLOGY, V94, pA247

← 1 2 →